Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 20
1957 24
1958 25
1959 15
1960 2
1961 2
1965 6
1966 14
1967 17
1968 16
1969 9
1970 17
1971 34
1972 34
1973 56
1974 52
1975 59
1976 54
1977 52
1978 36
1979 59
1980 46
1981 41
1982 43
1983 41
1984 55
1985 51
1986 49
1987 37
1988 61
1989 65
1990 40
1991 63
1992 49
1993 44
1994 49
1995 58
1996 60
1997 70
1998 77
1999 87
2000 94
2001 124
2002 139
2003 123
2004 148
2005 166
2006 199
2007 229
2008 233
2009 245
2010 224
2011 243
2012 240
2013 252
2014 245
2015 214
2016 238
2017 226
2018 178
2019 92
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

5,077 results
Results by year
Filters applied: . Clear all
Page 1
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, Moreira-Maia CR, Magnusson FL, Holmskov M, Gerner T, Skoog M, Rosendal S, Groth C, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Håkonsen SJ, Aagaard L, Simonsen E, Gluud C. Storebø OJ, et al. Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2. Cochrane Database Syst Rev. 2018. PMID: 29744873 Free PMC article. Review.
The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression.
Liang EF, Lim SZ, Tam WW, Ho CS, Zhang MW, McIntyre RS, Ho RC. Liang EF, et al. Int J Environ Res Public Health. 2018 Aug 20;15(8):1789. doi: 10.3390/ijerph15081789. Int J Environ Res Public Health. 2018. PMID: 30127314 Free PMC article.
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson FL, Moreira-Maia CR, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Forsbøl B, Simonsen E, Gluud C. Storebø OJ, et al. Cochrane Database Syst Rev. 2015 Nov 25;(11):CD009885. doi: 10.1002/14651858.CD009885.pub2. Cochrane Database Syst Rev. 2015. PMID: 26599576 Review.
Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study.
Matthijssen AM, Dietrich A, Bierens M, Kleine Deters R, van de Loo-Neus GHH, van den Hoofdakker BJ, Buitelaar JK, Hoekstra PJ. Matthijssen AM, et al. Am J Psychiatry. 2019 Sep 1;176(9):754-762. doi: 10.1176/appi.ajp.2019.18111296. Epub 2019 May 21. Am J Psychiatry. 2019. PMID: 31109200 Clinical Trial.
ADHD and medication.
Nurs Stand. 2016 Jan 20;30(21):17. doi: 10.7748/ns.30.21.17.s20. Nurs Stand. 2016. PMID: 26786437
The use of methylphenidate in Michigan.
Rappley MD, Gardiner JC, Jetton JR, Houang RT. Rappley MD, et al. Arch Pediatr Adolesc Med. 1995 Jun;149(6):675-9. doi: 10.1001/archpedi.1995.02170190085015. Arch Pediatr Adolesc Med. 1995. PMID: 7767425
5,077 results
Jump to page
Feedback